Prof Development   |   Print Page   |   Contact Us   |   Sign In   |   Join SRNT
Treatment Network Leadership
Share |

Advisory Committee

Treatment Network Co-Chairs:

Lisa Fucito, Ph.D.

Lisa Fucito, PhD is an Assistant Professor of Psychiatry at the Yale School of Medicine and Director of the Tobacco Treatment Service at Smilow Cancer Hospital at Yale-New Haven Hospital. Her program of research is focused on developing novel interventions for smoking and heavy drinking and understanding moderators and mechanisms of treatment response. She currently has a career award from the National Institute of Alcohol Abuse and Alcoholism to develop and evaluate an integrated behavioral intervention for heavy-drinking smokers. Dr. Fucito is interested in treatments that promote multiple behavior change and are practical in primary healthcare settings. In addition to these research activities, Dr. Fucito serves as Co-Chair of the Treatment Network Committee of the Society for Research on Nicotine and Tobacco and is  an Associate Editor for the journal Nicotine & Tobacco Research.

 

 

Megan Piper, Ph.D.

Dr. Megan Piper is an Assistant Professor at the University of Wisconsin, Madison and the Associate Research Director of the UW Center for Tobacco Research and Intervention. Her research research focuses on understanding and treating tobacco dependence, with an additional interest in different populations of smokers who have more difficulty quitting, such as women and smokers with mental illness.  In 2014, Dr. Piper received the Russell-Jarvik Young Investigator Award for her contributions to the field from the Society for Research on Nicotine and Tobacco. Dr. Piper serves as an Associate Editor for the journal Nicotine & Tobacco Research.


 

 

 

Advisory Committee Members

 

Leonie Brose, Ph.D.

Dr Leonie Brose is a Lecturer in Addictions at the Institute of Psychiatry, Psychology and Neuroscience, King’s College London. She completed her PhD at Royal Holloway, University of London, followed by a post-doctoral position at University College London and the National Centre for Smoking Cessation and Training.


Her research has covered clinical effectiveness of stop smoking intervention, practitioner training and electronic cigarettes. In December 2015, she has started a Cancer Research UK/BUPA Foundation Fellowship in Cancer Prevention to focus on smoking cessation in smokers with mental health problems.

 

 

Anne M. Joseph, M.D., MPH

Dr. Joseph is a Wexler Professor of Medicine and general internist in the Department of Medicine. She received her medical training at the University of Michigan and received a Masters of Public Health in Epidemiology from the University of Minnesota. She is currently directing the Applied Clinical Research Program in the Department of Medicine. Her primary research interests are in tobacco control. Her work has focused on smoking cessation and smoking reduction interventions for special populations of smokers that experience unique barriers to delivery of tobacco treatment. Dr. Joseph is past president of the Society for Research on Nicotine and Tobacco, Co-Chair of the Medical School Promotion and Tenure Committee and a member of the University of Minnesota Women’s Faculty Cabinet.

 

 

Jennifer McClure, Ph.D.

Dr. Jennifer McClure is Director of Research, Faculty & Development and Senior Investigator at the Group Health Research Institute; Affiliate Professor at the University of Washington's School of Public Health; Affiliate Investigator at the Fred Hutchinson Cancer Research Center; and a licensed clinical psychologist.  Dr. McClure's research focuses the development and evaluation of nicotine dependence treatment programs with an emphasis in  technology-based interventions (eHealth and mHealth interventions), population-level interventions, and motivational interventions for smoking cessation. Dr. McClure has served as Associate Editor for N&TR since 2006, co-chaired the SRNT Treatment Network from 2012-2015, and will serve as the SRNT Member Delegate At-large from 2016-2019.

 

 

 

Marc L. Steinberg, Ph.D.

Dr. Marc Steinberg is an Associate Professor of Psychiatry and Associate Director, Division of Addiction Psychiatry at Rutgers Robert Wood Johnson Medical School. Dr. Steinberg’s research focuses on tobacco use and dependence, including tobacco dependence treatment development, tobacco use in smokers with psychiatric comorbidity, the relationship between smoking and task persistence/distress tolerance, and motivational interviewing as an approach to encourage smokers to make a quit attempt.

 

In addition to serving on the SRNT Treatment Network’s Advisory Committee, Dr. Steinberg serves on the Treatment Network’s Communications Committee and the SRNT Electronic Communications Committee. He is a Deputy Editor for the journal Nicotine & Tobacco Research.

 

 

Benjamin Toll, Ph.D.

Dr. Benjamin Toll is licensed clinical psychologist, an Associate Professor of Public Health Sciences, Chief of Tobacco Cessation and Health Behaviors, and Co-Director of the Lung Cancer Screening program at the Hollings Cancer Center and the Medical University of South Carolina. He specializes in treatment of tobacco use disorders, alcohol use disorders, and improvement of health behaviors.

Dr. Toll has received grants from the National Institutes of Health, including the National Cancer Institute, and he is an author of over 65 peer-reviewed publications relating to nicotine and tobacco research, including a policy statement from the American Association for Cancer Research (AACR) encouraging physicians to provide tobacco treatment for cancer patients and the American College of Chest Physician (ACCP) treatment guidelines for smoking cessation amongst lung cancer patients. He is also holds leadership positions in national associations relating to tobacco treatment research. Dr. Toll is the Co-Chair of the Treatment Network of the Society for Research on Nicotine and Tobacco (SRNT), and a Member of the AACR Tobacco and Cancer Subcommittee.

 

Dr. Toll’s research has focused on testing novel smoking cessation treatments, and he has conducted numerous clinical trials in this regard. Many of his studies have investigated promotion of smoking cessation through novel message framing and motivational interventions, including those delivered via telephone and in person. Dr. Toll has tested several pharmacological and counseling interventions, and he also has expertise in the measurement of tobacco use and tobacco related syndromes (e.g., withdrawal, craving) and mediators and moderators of response to treatment. He has served as a reviewer for numerous peer-reviewed publications, including the Surgeon General’s Report (The Health Consequences of Smoking: 50 Years of Progress, Chapter: Cigarette Smoking and Adverse Health Outcomes in Cancer Patients and Survivors).



 

 

 

Return to SRNT homepage

Return to Treatment Network homepage

Return to Treatment Network Forum (formerly Treatment Network listserv)

(last updated 6/4/2016)


Connect With Us
Membership Management Software Powered by YourMembership  ::  Legal